Geriatric assessment and biomarkers in patients with metastatic breast cancer receiving first-line mono-chemotherapy: Results from the randomized phase III PELICAN trial

Honecker F, Harbeck N, Schnabel C, Wedding U, Waldenmaier D, Saupe S, Jäger E, Schmidt M, Kreienberg R, Müller L, Otremba B, Dorn J, Warm M Al-Batran SE, de Wit M; PELICAN investigators. J Geriatr Oncol. 2017 Oct 18. pii: S1879-4068(17)30195-9. doi: 10.1016/j.jgo.2017.09.009. [Epub ahead of print]